Working Groups (offered in-person only)
December 2, 2024

Day 1
December 3, 2024

7:30 am
Registration & Breakfast
8:15 am
Opening Remarks from the Co-Chairs
8:30 am
Drug and Medical Device Litigation Year in Review
9:30 am
Navigating the New Rule 702 Amendments: Strategies for Expert Testimony in Drug and Medical Device Litigation
10:30 am
Extended Networking Break
11:00 am
Audience Polling
AI v. ASSOCIATE: Rethinking the Role of AI in Legal Practice and Trial Strategy
12:00 pm
SPOTLIGHT ON NOVEL THEORIES
Decoding Novel Cases: Key Insights from Groundbreaking Rulings in Gilead, BMS, Bartlett, and More
1:00 pm
Networking Luncheon Sponsored by:  
Sponsor
2:15 pm
Keynote Address

BREAKOUT SESSIONS A

2:45 pm
Track 1: Bankruptcy as a Strategy in Mass Tort Litigation: The Risks and Rewards of an Expanding Settlement Approach
2:50 pm
Track 2: Countering Plaintiff Strategies: Tackling Expanded Liability Tactics
3:30 pm
Extended Networking Break

BREAKOUT SESSIONS B

3:45 pm
Track 1: Defeating Reptile Theory: Early Strategies to Control Your Case
3:50 pm
Track 2: From Nuclear Verdicts to Thermonuclear Verdicts: Evaluating the True Impact on Drug and Medical Device Manufacturers
4:30 pm
General Counsel and Heads of Litigation Roundtable: Strategic Insights on Navigating Drug and Medical Device Litigation Challenges
5:30 pm
Conference Adjourns, Cocktail Reception Sponsored by  
Sponsor

Day 2
December 4, 2024

8:15 am
Networking Breakfast
8:45 am
Opening Remarks from the Co-Chairs
9:00 am
A View From the Bench: Judicial Perspectives on Navigating Drug and Medical Device Products Liability Litigation

BREAKOUT SESSIONS C

10:00 am
Track 1: PFAS and Forever Chemicals: Understanding the Complex Legal Nuances of Contaminant Litigations
10:05 am
Track 2: AI in Drug Development and Medical Devices: Unpacking Liability Risks in the Life Sciences
10:45 am
Extended Networking Break

BREAKOUT SESSIONS D

11:00 am
Track 1: Data Privacy Minefields: Mastering FDA Compliance and Privacy Standards for Drug and Device Manufacturers
11:05 am
Track 2: Managing Multidistrict Litigation: How Proposed Rule 16.1 Could Transform Early MDL Management

BREAKOUT SESSIONS E

12:00 pm
Audience Polling
Track 1: Driving Success in DEI: Strategies for Enhancing Diversity, Equity & Inclusion in Your Litigation Teams
12:05 pm
Audience Polling
Track 2: Mastering Jury Selection: A Hands-On Demonstration for Drug and Device Litigation
1:00 pm
Networking Luncheon
2:00 pm
Keynote Address
2:30 pm
“Get Us Out of This!”: Developing and Implementing an Exit Strategy to Conclude Drug and Device Litigation
3:15 pm
Extended Networking Break
3:45 pm
Ethics Lab: Avoiding Ethical Compliance Traps in Drug and Medical Device Litigation
4:30 pm
Conference Concludes